Drug Target Review
NOVEMBER 27, 2023
About the author Dr Steve Worland President & Chief Executive Office, eFFECTOR Therapeutics Dr Steve Worland has served as our President and Chief Executive Officer and as a member of our board of directors since our inception in May 2012. Previously, Dr Worland served as Chief Executive Officer of Anadys Pharmaceuticals, Inc.,
Broad Institute
JULY 13, 2023
Nature Methods, 2012]. Nature Methods, 2012]. Funding Support for this work was provided by the National Institutes of Health, the Chan Zuckerberg Initiative DAF through the Silicon Valley Community Foundation, the European Molecular Biology Laboratory, and a Morgridge Postdoctoral Fellowship.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
MAY 27, 2024
Dr Heather O’Neill, PhD, Caris Life Sciences VP of Precision Medicine Dr Heather O’Neill joined Caris Life Sciences in 2012 and currently serves as Vice President of Precision Medicine. His work has been published in many high-impact journals and presented at international oncology meetings.
Codon
JULY 17, 2024
Backyard astronomers discovered 42 new planets in 2012 , hobbyist paleontologists discovered the world’s largest dinosaur footprint near the Yorkshire coast in 2021, and Sebastian himself open-sourced protocols that make it easier for scientists to engineer plants.
Broad Institute
OCTOBER 16, 2024
He has a humble, self-effacing demeanor, and yet he is great at pushing people to make bold bets and to try to make the impossible possible."
Drug Target Review
AUGUST 29, 2024
He holds multiple utility and design patents for scientific technologies and has authored various peer-reviewed manuscripts in the fields of bacteriology, virology, immunology, molecular biology, and cancer immunotherapy.
Codon
DECEMBER 17, 2023
Molecular biology, as the field came to be called 3 , pushed biology from an object of study, driven forward by gentleman scientists and precocious country clergymen, into a tool with which to solve urgent problems. CRISPR gene-editing was invented in 2012 and applied to human embryos soon after.
Expert insights. Personalized for you.
86 
Let's personalize your content